Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky M V
Laboratory of Immunology, NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 1997 Oct 10;272(41):25881-9. doi: 10.1074/jbc.272.41.25881.
Accumulation of extracellular and intracellular adenosine (Ado) under hypoxic conditions or in the absence of adenosine deaminase results in lymphocyte depletion and in severe combined immunodeficiency, which are currently explained by direct intracellular lymphotoxicity of Ado metabolites. In support of the alternative, "signaling" mechanism, we show that extracellular Ado (extAdo) suppresses all tested T cell receptor (TCR)-triggered effector functions of T lymphocytes including the TCR-triggered FasL mRNA up-regulation in cytotoxic T lymphocytes. Strong evidence against the intracellular lymphotoxicity of Ado (and in support of the signaling model) is provided by abrogation of TCR-triggered growth inhibition in Ado-exposed T cells. The brief exposure to Ado was sufficient to observe inhibition of TCR-triggered effector functions. The "memory" of T cells to exposure to extAdo is best explained by sustained increases in cAMP. Selective agonist (CGS21680) and antagonist (ZM241385) of A2A adenosine receptor were used in functional assays and cDNA probes for different sybtypes of adenosine receptors were used in Northern blot studies. A2A receptors are identified as the predominantly expressed subtype of Gs-coupled Ado receptors in T cells. The demonstration of cross-talk between the A2A receptors and TCR in both directions support the possible role of A2A receptors in mechanisms of extAdo-mediated immunosuppression in vivo under adenosine deaminase deficiency and hypoxic conditions in, e.g., solid tumors.
在缺氧条件下或缺乏腺苷脱氨酶时,细胞外和细胞内腺苷(Ado)的积累会导致淋巴细胞耗竭和严重联合免疫缺陷,目前认为这是由Ado代谢产物的直接细胞内淋巴毒性所致。为支持另一种“信号传导”机制,我们发现细胞外Ado(extAdo)可抑制所有测试的T淋巴细胞T细胞受体(TCR)触发的效应功能,包括细胞毒性T淋巴细胞中TCR触发的FasL mRNA上调。在暴露于Ado的T细胞中,TCR触发的生长抑制被消除,这为反对Ado的细胞内淋巴毒性(并支持信号传导模型)提供了有力证据。短暂暴露于Ado足以观察到TCR触发的效应功能受到抑制。T细胞对extAdo暴露的“记忆”最好用cAMP的持续增加来解释。在功能测定中使用了A2A腺苷受体的选择性激动剂(CGS21680)和拮抗剂(ZM241385),在Northern印迹研究中使用了针对不同亚型腺苷受体的cDNA探针。A2A受体被确定为T细胞中Gs偶联Ado受体的主要表达亚型。A2A受体与TCR之间双向串扰的证明支持了A2A受体在例如实体瘤中腺苷脱氨酶缺乏和缺氧条件下extAdo介导的体内免疫抑制机制中的可能作用。